Induction of Epstein-Barr virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoid B cell lines

Molecular and Cellular Biochemistry

Volumn 324, Issue 1-2, 2009, Pages 55-63

  Gargouri, Bochra ^a,b   Van Pelt, Jos ^c   El Feki, Abd El Fatteh ^d   Attia, Hammadi ^a   Lassoued, Saloua ^a  

^a Université de Sfax   (Tunisia)

^b University Hospital Gasthuisberg ^*  (Tunisia)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d UNIVERSITY OF SFAX   (Tunisia)

Author keywords

Epstein Barr virus; Lymphoblastoid B cell lines; Lytic cycle; Oxidative stress

Indexed keywords

CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; LIPID; MALONALDEHYDE; PHORBOL 13 ACETATE 12 MYRISTATE; SUPEROXIDE DISMUTASE;

ARTICLE; CONTROLLED STUDY; DAUDI CELL; ENZYME ACTIVITY; EPSTEIN BARR VIRUS; GLUTATHIONE METABOLISM; HUMAN; HUMAN CELL; IN VITRO STUDY; LIPID PEROXIDATION; LYMPHOBLASTOID CELL LINE; MALIGNANT TRANSFORMATION; NONHUMAN; OXIDATIVE STRESS; RAJI CELL; VIRUS CELL INTERACTION; VIRUS REPLICATION;

ANTIOXIDANTS; BIOLOGICAL MARKERS; CELL LINE, TUMOR; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; LEUKEMIA, B-CELL; OXIDANTS; OXIDATIVE STRESS; OXIDOREDUCTASES;

HUMAN HERPESVIRUS 4;

EID: 61549096573     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9984-1     Document Type: Article

References (60)

1. Babkock JG, Decker LL, Volk M et al (1998) EBV persistence in memory B cells in vivo. Immunity 3:395-404. doi: 10.1016/S1074-7613(00)80622-6
2. Tierney RJ, Steven N, Young LS et al (1994) Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J Virol 68:7374-7385
3. Anagnostopoulus I, Hummel M, Kreschel C et al (1995) Morphology, immunophenotype, and distribution of latently and/or productively Epstein-Barr virus-infected cells in acute infectious mononucleosis: implications for the interindividual infection route of Epstein-Barr virus. Blood 3:744-750
4. Sixbey JW, Nedrud JG, Raab-Traub N et al (1984) Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 19:1225-1230
5. Crawford DH (2001) Biology and disease associations of Epstein-Barr virus. Philos Trans R Soc Lond B Biol Sci 356:461-473. doi: 10.1098/ rstb.2000.0783
6. Speck SH, Chatila T, Flemington E (1997) Reactivation of Epstein-Barr virus: Regulation and function of the BZLF1 gene. Trends Microbiol 5:399-405. doi: 10.1016/S0966-842X(97)01129-3
7. Zur Hausen H, O'Neil F, Freese U (1978) Persisting oncogenic herpes viruses induced by the tumor promoter TPA. Nature 272:373-375. doi: 10.1038/272373a0
8. Hampar B, Derge JG, Martos LM et al (1973) Identification of a critical period during the S phase for activation of the Epstein-Barr virus by 5-iododeoxyuridine. Nat New Biol 244:214-217
9. Luka J, Kallin B, Klein G (1979) Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n -butyrate. Virology 94:228-231. doi: 10.1016/0042-6822(79)90455-0
10. Faggioni A, Zompetta C, Grimaldi S et al (1986) Calcium modulation activates Epstein-Barr virus genome in latently infected cells. Science 232:1554-1556. doi: 10.1126/science.3012779
11. Fahmi H, Cochet C, Hmama Z et al (2000) Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway. J Virol 74:5810-5818. doi: 10.1128/ JVI.74.13.5810-5818.2000
12. Takada K (1984) Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt lymphoma lines. Int J Cancer 33:27-32. doi: 10.1002/ijc.2910330106
13. Brady G, Mac Arthur GJ, Fanel PJ (2007) Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol 60:1397-1402
14. Raab-traub N (1992) Epstein-Barr virus and nasopharyngeal carcinoma. Semin Cancer Biol 3:297-307
15. Takada K (1999) Epstein-Barr virus and gastric carcinoma. EBV Rep 6:95-100
16. Humme S, Reisbach G, Feederle R et al (2003) The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci USA 100:10989-10994. doi: 10.1073/pnas.1832776100
17. Kitagawa N, Goto M, Kurozumi K et al (2000) Epstein-Barr virus-encoded poly (A) RNA supports Burkitt's lymphoma growth through interleukin-10 induction. EMBO J 19:6742-6750. doi: 10.1093/emboj/19.24.6742
18. Tomkinson B, Robertson E, Kieff E (1993) Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol 67:2014-2025
19. Jones TG, Wood JD (1996) Oxidant production by human B lymphocytes: detection of activity and identification of components involved. Methods 9:619-627. doi: 10.1006/meth.1996.0068
20. Cerimele F, Battle T, Lynch R et al (2005) Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr virus (EBV)-positive versus EBV-negative Burkitt's lymphoma. Proc Natl Acad Sci USA 102:175-179. doi: 10.1073/pnas.0408381102
21. Dalpke AH, Thomssen R, Ritter K (2003) Oxidative injury to endothelial cells due to Epstein-Barr virus-induced autoantibodies against manganese superoxide dismutase. J Med Virol 3:408-416. doi: 10.1002/jmv.10501
22. Valko M, Leibfritz D, Moncol J et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44-84. doi: 10.1016/j.biocel.2006.07.001
23. Valko M, Rhodes CJ, Moncol J et al (2006) Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact 160:1-40. doi: 10.1016/j.cbi.2005.12.009
24. Kovacic P, Jacintho JD (2001) Mechanisms of carcinogenesis. Focus on oxidative stress and electron transfer. Curr Med Chem 8:773-796
25. Ridnour LA, Isenberg JS, Espey MG et al (2005) Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci USA 102:13152-13747. doi: 10.1073/pnas.0502979102
26. Valko M, Morris H, Mazur M et al (2001) Oxygen free radical generating mechanisms in the colon: Do the semiquinones of vitamin K play a role in the aetiology of colon cancer? Biochim Biophys Acta 1527:161-166
27. Ames BN (1983) Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative disease. Science 221:1256-1264. doi: 10.1126/ science.6351251
28. Fridovich I (1978) The biology of oxygen radicals. Science 201:875-880. doi: 10.1126/science.210504
29. Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121-126
30. Yung-Chi C (1980) Studies on the activity of DNase associated with the replication of the Epstein-Barr virus. Virology 100:334-338
31. Kieff E (1996) Epstein-Barr virus and its replication. In: Field BN, Knipe NM, Howley PM et al (eds) Fields virology, 3rd edn. Lippincott-Raven Publishers, Philadelphia
32. Miller G, Lipman M (1973) Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc Natl Acad Sci USA 70:190-194
33. Oh HM, Oh JM, Choi SC et al (2003) An efficient method for the rapid establishment of Epstein-Barr virus immortalization of human B lymphocytes. Cell Prolif 36:191-197
34. Fachiroh J, Schouten T, Hariwiyanto B et al (2004) Molecular diversity of Epstein-Barr virus IgG and IgA antibody responses in nasopharyngeal carcinoma: A comparison on Indonesian, Chinese, and European subjects. J Infect Dis 190:53-62
35. Akerboom TPM, Sies H (1981) Assay of glutathione, glutathione disulfide, and glutathione mixed disulfides in biological samples. Methods Enzymol 77:373-382
36. Marklund S, Marklund G (1974) Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 3:469-474
37. Steghens JP, Van Kappel AL, Denis I et al (2001) Diaminophthalene, a new highly specific reagent for HPLC-UV measurement of total and free malondialdehyde in human plasma or serum. Free Radic Biol Med 31:242-249
38. Lassoued S, Ben Ameur R, Ayadi W et al (2008) Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines. Mol Cell Biochem 313:179-186
39. Zhang M, Liu L, Cheng L et al (2003) Express of plasma ROS, SOD and GSH-PX in patients with nasopharyngeal carcinoma. Lin Chuang Er Bi Yan Hou Ke Za Zhi 11:650-651
40. Montone KT, Hodinka RL, Salhany KE et al (1996) Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease. Mod Pathol 9:621-630
41. Tao Q, Robertson KD, Manns A et al (1998) Epstein-Barr virus (EBV) in endemic Burkitt's lymphoma: Molecular analysis of primary tumor tissue. Blood 91:1373-1381
42. Hong GK, Gulley ML, Feng WH et al (2005) Epstein-Barr virus infection contributes to lymphoproliferative disease in SCID mose model. J Virol 79:13993-14003
43. Spieker T, Herbst H (2000) Distribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease. Am J Pathol 1:51-57
44. Regöly-Merei A, Bereczky M, Arató G et al (2007) Nutritional and antioxidant status of colorectal cancer patients. Orv Hetil 148:1505-1509
45. Toussirot E, Roudier J (2007) Pathophysiological links between rheumatoid arthritis and the Epstein-Barr virus: An update. Joint Bone Spine 74:418-426
46. Sarban S, Kocyigit A, Yazar M et al (2005) Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis. Clin Biochem 38:981-986
47. Niedobitek G, Agathanggelou A, Herbst H et al (1997) Epstein-Barr virus (EBV) infection in infectious mononucleosis: Virus latency, replication and phenotype of EBV-infected cells. J Pathol 182:151-159
48. Prang NS, Hornef MW, Jäger M et al (1997) Lytic replication of Epstein-Barr virus in the peripheral blood: Analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 89:1665-1677
49. Qadri I, Iwahashi M, Capasso JM et al (2004) Induced oxidative stress and activated expression of manganese superoxide dismutase during hepatitis C virus replication: Role of JNK, p38 MAPK and AP-1. Biochem J 378:919-928
50. Severi T, Ying C, Vermeesch JR et al (2006) Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells. Mol Cell Biochem 290:79-85
51. Dikalov S, Wei L, Mehrampour P et al (2007) Production of extracellular superoxide by human lymphoblast cell lines: Comparison of electron spin resonance techniques and cytochrome C reduction assay. Biochem Pharmacol 9290:1-9
52. Dröge W (2002) Free radicals in the physiological control of cell function. Physiol Rev 82:47-95
53. Abdalla MY, Ahmad IM, Spitz DR et al (2005) Hepatitis C virus-core and non structural proteins lead to different effects on cellular antioxidant defenses. J Med Virol 76:489-497
54. Biggin M, Bodescot M, Perricaudet M et al (1987) Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells. J Virol 61:3120-3132
55. De Turenne-Tessier M, Ooka T, De The G et al (1986) Characterization of an Epstein-Barr virus-induced thymidine kinase. J Virol 57:1105-1112
56. Ooka T, Calender A, de Turenne M et al (1983) Effect of arabinofuranosylthymine on the replication of Epstein-Barr virus and relationship with a new induced thymidine kinase activity. J Virol 46:187-195
57. Ooka T, Lenoir G, Decaussin G et al (1986) Epstein-Barr virus-specific DNA polymerase in virus-nonproducer Raji cells. J Virol 58:671-675
58. LaJeunesse DR, Brooks K, Adamson AL (2005) Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 alter mitochondrial morphology during lytic replication. Biochem Biophys Res Commun 333:438-442
59. Korenaga M, Wang T, Li Y et al (2005) Hepatitis C virus core protein inhibits mitochondrial electron transport and increases reactive oxygen species (ROS) production. J Biol Chem 280:37481-37488
60. Bureau C, Bernard J, Chaouche N et al (2001) Nonstructural 3 protein of hepatitis C virus triggers an oxidative burst in human monocytes via activation of NADPH oxidase. J Biol Chem 276:23077-23083